In this Quick Case, Endocrinologist A/Prof Samantha Hocking, outlines evidence from the SURMOUNT-MAINTAIN study, demonstrating how Mounjaro® dose reduction or elimination impacts the maintenance of weight loss, cardiometabolic benefits, and clinical decision-making in obesity management (5 mins).
